Semax 10 mg

Description

Semax 10mg is supplied as lyophilized powder with a labeled amount of 10mg per vial, for in-vitro laboratory research only.

Semax is a synthetic peptide studied in neuroregulatory research. This listing provides the labeled product amount and separate analytical documentation for the current batch.

Product specifications

• Peptide: Semax
• Label amount: 10mg per vial
• Form: lyophilized powder
• Product format: standalone Semax research material

The 10mg label amount identifies this product; it is not a concentration in mg/mL. Measured analytical results are reported separately for the tested batch.

Current batch and analytical results

BT Labs report IF-824-QSA-TR006-BTL26566-04 documents batch CP-SMX10-2606-01. The sample was tested on 25 May 2026; the report is dated 27 May 2026.

• Identity: FTIR confirms the presence of Semax with excipients/fillers.
• HPLC purity: 99.7%
• HPLC potency: 10.3 mg

These results apply to the tested sample from this batch and are not guarantees for every vial or future batch. Identity, purity and potency testing do not establish sterility or endotoxin status.

Read the Semax batch CP-SMX10-2606-01 complete COA (complete two-page PDF). Use the batch number on your product documentation to find the matching record in Currently Shipping COAs or the Batch Ledger.

Semax research information

For educational context, see the Semax research overview. Research background does not establish benefits or suitability for human or veterinary use.

Standalone product and related blend

This page is for standalone Semax with a 10mg label amount. The separate Semax + Selank 10mg + 10mg blend contains 10mg of each peptide, or 20mg combined. Its batch documentation is separate from this product’s COA. Standalone Selank 10mg is also available.

Research use only

For laboratory research only. Not for human or veterinary use, diagnosis or treatment. See the research-use-only information.